Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Qual Life Res. 2018 Sep 15;28(1):47–56. doi: 10.1007/s11136-018-2002-5

Table 2.

Participant Demographics

Demographic Patient (N=223) N (%) Surrogate (N=226) N (%)
Gender
 Male 125 (56.1) 99 (43.8)
 Female 94 (42.2) 126 (55.8)
 Transgender 4 (1.8) 1 (0.4)
Age
 22–39 years 44 (19.7) 60 (26.5)
 40–60 years 128 (57.4) 112 (49.6)
 61–77 years 51 (23.0) 54 (23.9)
Race
 American Indian or Alaska Native 1 (0.5) 2 (0.9)
 Asian 0 (0.0) 1 (0.4)
 Black or African American 192 (86.1) 190 (84.1)
 White/Caucasian 19 (8.5) 21 (9.3)
 Bi-Racial 5 (2.2) 4 (1.8)
 Declined 6 (2.7) 8 (3.5)
Ethnicity
 Hispanic/Latino 8 (3.6) 9 (4.0)
 Non-Hispanic/Non-Latino 202 (90.6) 205 (90.7)
 Declined 13 (5.8) 12 (5.3)
Sexual Orientation
 Heterosexual 148 (66.4) 156 (69.0)
 Non-Heterosexual 75 (33.6) 70 (31.0)
Education
 High School or Lower 93 (41.7) 103 (45.6)
 Some College or Higher 130 (58.3) 123 (54.4)
Income
 Equal, Below Federal Poverty Line 86 (39.5) 67 (30.7)
 Higher than Federal Poverty Line 87 (39.9) 105 (48.2)
 Unknown/Unreported 45 (20.6) 54 (23.9)
a.

This table describes the demographic information about the patients and surrogates in the FACE ACP clinical trial for adult PLWH.